Sandoz product recalled over manufacturing violations
- Recall date
- September 23, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Sandoz, Inc recalls Sandoz Ranitidine Hydrochloride Capsules 150mg 60 Capsules Rx Only Manufactured by Sandoz Inc. Princeton, NJ Product of…
- Recall number
- D-0127-2020
- FDA classification
- Class II
- Brand / firm
- Sandoz, Inc
- Sold / distributed
- U.S. Nationwide
Why it was recalled
CGMP Deviations: Detection of a trace amount of an unexpected impurity, N-nitrosodimethylamine (NDMA).
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Sandoz Ranitidine Hydrochloride Capsules 150mg 60 Capsules Rx Only Manufactured by Sandoz Inc. Princeton, NJ Product of India NDC 0781-2855-60
Get recall alerts
Free email alert whenever Sandoz, Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Sandoz, Inc